Lataa...
Teplizumab therapy for type 1 diabetes
IMPORTANCE OF THE FIELD: Type 1 diabetes mellitus (T1D) is a T cell mediated autoimmune disease with selective destruction of β-cells. Immunological interventions are directed at arresting the loss of β-cell function with the promise that this will make it easier for patients to control their glucos...
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2825571/ https://ncbi.nlm.nih.gov/pubmed/20095914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/14712591003598843 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|